Insider Selling at Stoke Therapeutics: Barry’s Plan‑Based Trades Reveal Gradual Unwinding
Insider selling continues at Stoke Therapeutics – Ticho Barry’s plan‑based June 1 sale shows steady, price‑neutral trades that may signal long‑term confidence for investors.
3 minutes to read



